News Further Debate on T3 + T4 Combination Therapy at ATA Meeting by Medscape • 2019/10/30 • 0 Comments The 89th annual meeting gets underway this week, with anaplastic thyroid cancer guidelines and combination T3 /T4 therapy among the highlights being discussed. Medscape Medical News Full Story →